The following is a summary of “Role of dormancy survival regulator and resuscitation-promoting factors antigens in ...

Even treated with the most advanced therapies, patients with glioblastoma—an aggressive brain cancer—typically survive less ...

The main tools used in the study of infectious diseases are recombinant antigens. They are frequently employed in the context of developing antibodies and vaccines. High-quality antigens and ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Biosimilars are a form of biological drugs ...

Therapeutics reports preclinical data showing strong anti-cancer activity of its next generation, personalized, off-the-shelf, ...

BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $127.53, ...

A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12)—a potent ...

Autoimmune responses to tissue-restricted self-antigens both humoral (antibody mediated) and cellular (predominantly of the IL-17 type) are pathogenic for chronic rejection. Alloimmune responses ...

Though technically not a CAR T-cell therapy, the agent "is not unlike CAR T-cell therapy in that we're redirecting T cells to ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.